Orlando, FL (PRWEB) August 02, 2012
The Yaz Resource Center, a patient advocacy group, is alerting women who suffered side effects after taking the birth control drugs Yaz or Yasmin that the maker of these drugs, Bayer, has pledged more money to settle blood clot injury claims filed by victims. However, only certain cases may qualify and the time to file a claim is limited.
Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.
Last October 25th, the British Medical Journal released a study from The University of Copenhagen linking the hormone in Yaz to blood clots. Two days later, the FDA released a report titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
Recently, the Institute for Safe Medicine Practices’ QuarterWatch published a study on May 31, 2012 ranking Yaz and Yasmin second among all drugs in 2011 for the number of complications reported to the FDA. Together, they resulted in more than 8,000 side-effect reports.
A federal Multi-District Litigation court was established in Illinois to handle the large number of Yaz lawsuits filed by patients. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates that over 10,000 patients have filed a claim so far.
Bloomberg News originally reported on April 13th that Bayer had begun settling Yaz lawsuits for approximately $220,000 per case. The company confirmed this in its’ 2012 first quarter Stockholders’ Newsletter, stating it had paid $142 million to settle over 600 Yaz cases.
Now, Bloomberg reports on July 31st that Bayer has settled nearly 1900 Yaz lawsuits over blood clots so far for just over $400 million, at an average of around $212,000, according to the most recent shareholders’ newsletter.
The stockholder report also indicated that Bayer has more than doubled its reserves to settle the cases to more than $610 million, according to the Bloomberg article. This could be positive news for those affected by the drug who have yet to file a claim.
Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.
The Yaz Resource Center cautions that only certain cases may be eligible for a Yaz settlement. Victims will also be required to submit proper medical records and paperwork. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.